Gene · 8647
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of noncoding RNA and its diagnostic potential in intrahepatic cholestasis of pregnancy: a research update. | Front Genet | 2023 | 37900174 | PubTator, text mining | PubMed |
| Challenges in Permeability Assessment for Oral Drug Product Development. | Pharmaceutics | 2023 | 37896157 | PubTator, text mining | PubMed |
| Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study. | Pharmaceuticals (Basel) | 2023 | 37895967 | PubTator, text mining | PubMed |
| Reproducibility and Robustness of a Liver Microphysiological System PhysioMimix LC12 under Varying Culture Conditions and Cell Type Combinations. | Bioengineering (Basel) | 2023 | 37892925 | PubTator, text mining | PubMed |
| Harnessing Oleanolic Acid and Its Derivatives as Modulators of Metabolic Nuclear Receptors. | Biomolecules | 2023 | 37892147 | PubTator, text mining | PubMed |
| Artificial Intelligence/Machine Learning-Driven Small Molecule Repurposing via Off-Target Prediction and Transcriptomics. | Toxics | 2023 | 37888725 | PubTator, text mining | PubMed |
| The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery. | Metabolites | 2023 | 37887384 | PubTator, text mining | PubMed |
| Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine. | Front Microbiol | 2023 | 37860132 | PubTator, text mining | PubMed |
| The Role of Inflammation in Cholestatic Liver Injury. | J Inflamm Res | 2023 | 37854312 | PubTator, text mining | PubMed |
| Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic cholestasis of pregnancy: The sum of the parts. | PLoS One | 2023 | 37851654 | PubTator, text mining | PubMed |
| Gallstone Disease and Its Correlation With Thyroid Disorders: A Narrative Review. | Cureus | 2023 | 37842424 | PubTator, text mining | PubMed |
| Exploring genetic influences on adverse outcome pathways using heuristic simulation and graph data science. | Comput Toxicol | 2023 | 37829618 | PubTator, text mining | PubMed |
| Recurrent early-onset severe obstetric cholestasis in a patient with two variants in the ABCB4 gene. | Hepatol Forum | 2023 | 37822304 | PubTator, text mining | PubMed |
| Dietary supplementation with garcinol during late gestation alleviates disorders of bile acid metabolism and improves the performance of sows and newborn piglets. | J Anim Sci | 2023 | 37819678 | PubTator, text mining | PubMed |
| Yinzhihuang injection induces apoptosis and suppresses tumor growth in acute myeloid leukemia cells. | PLoS One | 2023 | 37816017 | PubTator, text mining | PubMed |
| The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug-Drug Interaction in Healthy Participants. | Eur J Drug Metab Pharmacokinet | 2023 | 37804430 | PubTator, text mining | PubMed |
| Differences in Exposure to Minimally Invasive Surgery in a Sample of United States Obstetrics and Gynecology Residents. | Cureus | 2023 | 37791220 | PubTator, text mining | PubMed |
| Significance of expression of selected miRNAs in the diagnosis of hepatological complications of Epstein-Barr virus infection in children. | Clin Exp Hepatol | 2023 | 37790684 | PubTator, text mining | PubMed |
| A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessment. | Toxicol Sci | 2023 | 37788119 | PubTator, text mining | PubMed |
| Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery. | Cureus | 2023 | 37779744 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8647/papers?page=13